
NANOTEMPER TECHNOLOGIES, INC.
At NanoTemper, we have one clear goal: a world where every disease is treatable.
This vision prompts us to empower scientists with biophysical solutions they trust, helping them discover life-saving therapies—even the toughest ones.
As a 100% founder-owned company, we are driven by a vision to continuously pioneer groundbreaking ideas, redefine what’s possible, and push boundaries. Innovation is in our DNA, driving our commitment to precision, uncompromising quality, and strong, collaborative partnerships with our customers.
That’s why we develop the highest-quality instruments, delivering reliable and precise results. Made to be easy-to-learn, easy-to-use, and automation-ready, our solutions streamline workflows while increasing efficiency. We support our customers with in-depth knowledge and scientific expertise at every stage of their journey, ensuring they achieve their goals.
Since 2008, leading pharmaceutical companies, biotech firms, and research institutions have relied on our solutions to accelerate drug development. And this was just our beginning: we’re advancing into biomanufacturing with end-to-end, GMP-compliant solutions supporting the entire drug development process—from discovery to release.
CONTACT INFORMATION
NanoTemper Technologies, Inc.
400 Oyster Point Blvd. Suite 336
South San Francisco, CA 94080
UNITED STATES
Contact: Léa Valla
E-BOOK
-
Optimize your lab's purchasing decisions for binding affinity solutions. Learn to quantify binding affinity, understand its significance in biological processes, and explore the tools available to advance your research.
-
Explore this guide to using nano-differential scanning fluorimetry (nanoDSF) and how it can impact and improve your screening data quality
-
Techniques to measure biotherapeutics stability and how they support biologics development, formulation, and storage for successful approval of your mAb-based therapeutic on the market.
-
Learn about Dynamic Light Scattering (DLS), a powerful method to characterize the purity and aggregation state of your biologics, and how it helps improve your candidates’ selection process.
FEATURED ARTICLES
-
Maximize your research potential by overcoming workflow bottlenecks. This piece explores flexible strategies for increasing throughput and integrating automation seamlessly into your laboratory operations.
-
Technological advancements are driving significant change in biomanufacturing. An industry expert highlights three pivotal areas: data science, advanced automation, and process analytical technologies.
-
Gain valuable perspectives on the future of biomanufacturing, including the impact of data science, automation, and continuous learning, shared by an experienced biophysics specialist in the field.
-
Discover how the biotinylated target labeling kit enables efficient screening and validation of challenging targets using spectral Shift and SPR technologies in your drug discovery process.
-
Mark your calendar for these five pivotal biologics conferences in 2025, offering a unique blend of scientific insights, networking, and glimpses into the future of biotherapeutics.
-
Learn how Pierre Fabre Laboratories streamlined their antibody development with the implementation of a new platform, enabling efficient and multi-parameter stability measurements.
-
See how Cube Biotech and MIT researchers used dynamic light scattering (DLS) and nano differential scanning fluorimetry (nanoDSF) to find the best nanodisc conditions for three membrane proteins.
-
Explore four essential questions to ask yourself when developing a PROTAC molecule to ensure you’re on the right track to protein degradation success.
-
Membrane proteins are vital for drug discovery, but traditional techniques can disrupt their structure. This study showcases a new method that maintains native conformation during analysis.
-
Formulation development is a vital part of the drug development process. Explore key factors to consider in pre-formulation.
-
Review how different excipients stabilize biologics in unique ways and are important considerations in the pre-formulation stage.
-
This article outlines the process of conducting thermal stability experiments and the significance of self-association parameters.
-
Explore the construction of ADCs (antibody-drug conjugates), as well as importance of stability and engineering considerations in the development process.
-
Thermal stability is one of the most common critical quality attributes of therapeutic proteins. Learn about 4 methods for thermal stability assessment of proteins.
-
Review what light scattering techniques tell you, how to set them up, and how they’re used for developability assessment.
-
Learn more about stability studies specifically and how to gain insight on multiple stability parameters on your biologics candidates all at once.
-
Biophysical characterization measurements from nanoDSF, DLS, backreflection, and SLS, are valuable to provide stability attributes of your biologics.
-
Developability profiles of biologics candidates help you avoid risk by collecting many quality attributes. Learn which attributes are evaluated during development and approaches for their measurement.
-
Explore questions about how to use Dynamic Light Scattering to design, select, and advance the most stable biologics candidates.
-
Learn how biologics scientists use DLS to get more detailed and reliable insights into their candidates so they de-risk downstream development.